XWELL (DB:V9G0) - Prezzo delle azioni, notizie e analisi

V9G0 Panoramica delle azioni

Provides health and wellness services in airport and off airport marketplaces in the United States and internationally. Maggiori dettagli

V9G0 analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	1/6
Prestazioni passate	0/6
Salute finanziaria	5/6
Dividendi	0/6

Premi

Si prevede che i ricavi cresceranno 14.56% all'anno

Analisi del rischio

Le azioni sono altamente illiquide

Non ha una capitalizzazione di mercato significativa ( €7M )

Ha meno di 1 anno di pista di cassa

Attualmente non redditizio e non si prevede che diventerà redditizio nei prossimi 3 anni

XWELL, Inc. Concorrenti

Erlebnis Akademie

DB:EAD

€8.3m

Oberstdorfer Bergbahn

MUN:KVO

€5.7m

123fahrschule

DB:123F

€12.6m

International School Augsburg -ISA- gemeinnützige

DB:9JK

€3.5m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per XWELL
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$0.12
Massimo di 52 settimane	US$9.18
Minimo di 52 settimane	US$2.16
Beta	2.5
1Variazione di 1 mese	0%
Variazione a 3 mesi	-94.63%
Variazione di 1 anno	-98.27%
3Variazione a 3 anni	-99.43%
Variazione a 5 anni	-99.91%
Variazione dall'IPO	-100.00%

Notizie e aggiornamenti recenti

Recent updates

Rendimenti per gli azionisti

	V9G0	DE Consumer Services	DE Mercato
7D	0%	1.5%	0.8%
1Y	-98.3%	28.4%	8.6%

Ritorno vs Industria: V9G0 ha avuto una performance inferiore rispetto al German Consumer Services che ha registrato un rendimento 28.4 % nell'ultimo anno.

Rendimento vs Mercato: V9G0 ha avuto una performance inferiore al mercato German che ha registrato un rendimento 8.6 % nell'ultimo anno.

Volatilità dei prezzi

Is V9G0's price volatile compared to industry and market?
V9G0 volatility
V9G0 Average Weekly Movement	n/a
Consumer Services Industry Average Movement	4.6%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Prezzo delle azioni stabile: Il prezzo delle azioni di V9G0 è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: Dati insufficienti per determinare la variazione della volatilità di V9G0 nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
n/a	433	Scott Milford	www.xwell.com

XWELL, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di XWELL con la sua capitalizzazione di mercato?
V9G0 statistiche fondamentali
Capitalizzazione di mercato	€6.64m
Guadagni(TTM)	-€31.44m
Ricavi(TTM)	€27.49m

0.2x

Rapporto P/S

-0.2x

Rapporto P/E

V9G0 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
V9G0 Conto economico (TTM)
Ricavi	US$30.26m
Costo del fatturato	US$27.05m
Profitto lordo	US$3.21m
Altre spese	US$37.83m
Guadagni	-US$34.61m

Ultimi guadagni dichiarati

Sep 30, 2023

Prossima data di guadagno

n/a

Utile per azione (EPS)	-8.28
Margine lordo	10.62%
Margine di profitto netto	-114.37%
Rapporto debito/patrimonio netto	0%

Come si è comportato V9G0 nel lungo periodo?

Vedi performance storica e confronto

V9G0 Panoramica delle azioni

Premi

Analisi del rischio

XWELL, Inc. Concorrenti

DB:EAD

€8.3m

MUN:KVO

€5.7m

DB:123F

€12.6m

DB:9JK

€3.5m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

XWELL, Inc. to Report Q3, 2024 Results on Nov 14, 2024

XWELL, Inc. Announces Executive Changes

XWELL, Inc., Annual General Meeting, Sep 20, 2024

CPC Decides to Withdraw Lawsuit Against XWELL

XWELL, Inc. has completed a Follow-on Equity Offering in the amount of $1.422897 million.

XWELL, Inc. has filed a Follow-on Equity Offering in the amount of $1.422897 million.

Recent updates

XWELL, Inc. to Report Q3, 2024 Results on Nov 14, 2024

XWELL, Inc. Announces Executive Changes

XWELL, Inc., Annual General Meeting, Sep 20, 2024

CPC Decides to Withdraw Lawsuit Against XWELL

XWELL, Inc. has completed a Follow-on Equity Offering in the amount of $1.422897 million.

XWELL, Inc. has filed a Follow-on Equity Offering in the amount of $1.422897 million.

CPC Pain & Wellness SPV Files Complaint in the Delaware Court of Chancery Against XWELL

CPC Pain & Wellness SPV Engages in Discussions with XWELL

XWELL, Inc. Introduces New Esthetic Facial Services to Naples Wax Center Locations

XWELL, Inc. Plans to Introduce the Ceragem V6 Therapeutic Thermal Massager in Select Xpresspa Locations

XWELL, Inc. Introduces IV Hydration Drip Therapy at Miami International Airport

XWELL, Inc. to Report Fiscal Year 2023 Results on Apr 16, 2024

XWELL, Inc. announced delayed amended 10-K filing

XWELL, Inc. announced delayed annual 10-K filing

XWELL, Inc. Elects Gaëlle S. Wizenberg as Member of the Audit Committee and the Compensation Committee

XWELL, Inc. Announces Board Changes, Effective January 1, 2024

XWELL, Inc. Introduces Clockwork Robotic Manicures At Harry Reid International Airport in Las Vegas

XWELL, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2023

XWELL, Inc. Announces 1-for-20 Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

XWELL, Inc. (NasdaqCM:XWEL) acquired Naples Wax Center, Inc.

New major risk - Share price stability

Second quarter 2023 earnings released: US$0.069 loss per share (vs US$0.083 loss in 2Q 2022)

XWELL, Inc. to Report Q2, 2023 Results on Aug 14, 2023

XWELL, Inc., Annual General Meeting, Aug 22, 2023

Xpresspa Debuts Clockwork Robotic Manicures At Miami International Airport

New major risk - Share price stability

XWELL, Inc. Announces Executive Changes, Effective July 10, 2023

First quarter 2023 earnings released: US$0.066 loss per share (vs US$0.042 loss in 1Q 2022)

XWELL, Inc. to Report Q1, 2023 Results on May 15, 2023

XWELL, Inc. Names Valerie Lightfoot Chief Financial Officer

Full year 2022 earnings released: US$0.35 loss per share (vs US$0.032 profit in FY 2021)

Third quarter 2022 earnings released: US$0.076 loss per share (vs US$0.053 profit in 3Q 2021)

XWELL, Inc. Announces Impairment Charges for the Three Months Ended September 30, 2022

XWELL, Inc. to Report Q3, 2022 Results on Nov 10, 2022

XWELL, Inc. Receives Non-Compliance Letter from the Nasdaq

XpresSpa Group, Inc. Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

XpresSpa Group, Inc., Annual General Meeting, Oct 04, 2022

XpresSpa Group Announces the Re-Opening of XpresSpa™ Location At John F. Kennedy International Airport’s Terminal 4

XpresSpa Group, Inc. to Report Q2, 2022 Results on Aug 15, 2022

XpresSpa Group Announces the Separation of Service of Chief Financial Officer James Berry

XpresSpa Group, Inc. Revises Revenue Guidance for the Year 2022

First quarter 2022 earnings released: US$0.042 loss per share (vs US$0.01 loss in 1Q 2021)

XpresSpa Group, Inc. to Report Q1, 2022 Results on May 16, 2022

Xpresspa Group, Inc. Announces Travel Health and Wellness Brand Treat™ Launches At Phoenix Sky Harbor International Airport

XpresSpa Group, Inc. Announces the Addition of Five New Xpresspa Locations in Istanbul

Investor sentiment improved over the past week

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

XpresSpa Group, Inc. Announces Resignation of Douglas Satzman as President

XpresSpa Group, Inc. (NasdaqCM:XSPA) entered into an acquisition agreement to acquire Gcg Connect Llc.

Independent Chairman of the Board recently bought €57k worth of stock

Forecast to breakeven in 2022

Third quarter 2021 earnings released: EPS US$0.053 (vs US$0.10 loss in 3Q 2020)

Independent Chairman of the Board recently bought €131k worth of stock

Forecast to breakeven in 2022

First quarter 2021 earnings released: US$0.01 loss per share (vs US$1.74 loss in 1Q 2020)

Full year 2020 earnings released: US$2.03 loss per share (vs US$12.99 loss in FY 2019)

Xpresspa Group Signs Contract with Port of Seattle for an Xprescheck™ Covid-19 Pop-Up Testing Facility At Seattle-Tacoma International Airport

XpresSpa Group Signs Contract with Metropolitan Washington Airports Authority for XpresCheck™ COVID-19 Testing Facilities at Dulles International Airport and Reagan National Airport

New 90-day high: €2.34